Zhang Haonan,Zhang Haijun,Fang Hai.Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China[J].2313872,2024,20(1):2313872.

Zhang Haonan,Zhang Haijun,Fang Hai.(2024).Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.

Zhang Haonan,Zhang Haijun,and Fang Hai."Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China."2313872 20.1(2024):2313872.

Sun Xiang,Zhang Tingting,Sun Jinning,et al.The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic[J].2331438,2024,20(1):2331438.

Sun Xiang,Zhang Tingting,Sun Jinning,Zhou Juan,Chen Qiang,Jia Chengmei...Wang Wen.(2024).The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic.

Sun Xiang,Zhang Tingting,Sun Jinning,Zhou Juan,Chen Qiang,Jia Chengmei,Xu Yan,Wu Yun,Wang Zhiguo,and Wang Wen."The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic."2331438 20.1(2024):2331438.

Mane Viraj,Mehta Rikin,Alvarez Nadine,et al.In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19[J].2303226,2024,20(1):2303226.

Mane Viraj,Mehta Rikin,Alvarez Nadine,Sharma Vijeta,Park Steven,Fox Alisa...Powell Rebecca L. R..(2024).In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19.

Mane Viraj,Mehta Rikin,Alvarez Nadine,Sharma Vijeta,Park Steven,Fox Alisa,DeCarlo Claire,Yang Xiaoqi,Perlin David S.,and Powell Rebecca L. R.."In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19."2303226 20.1(2024):2303226.

Kardos Peter,de Sousa Jaime Correia,Heininger Ulrich,et al.Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations[J].2324547,2024,20(1):2324547.

Kardos Peter,de Sousa Jaime Correia,Heininger Ulrich,Konstantopoulos Andreas,MacIntyre C. Raina,Middleton Donald...von Koenig Carl Heinz Wirsing.(2024).Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations.

Kardos Peter,de Sousa Jaime Correia,Heininger Ulrich,Konstantopoulos Andreas,MacIntyre C. Raina,Middleton Donald,Nolan Terry,Papi Alberto,Rendon Adrian,Rizzo Albert,Sampson Kim,Sette Alessandro,Sobczyk Elizabeth,Tan Tina,Weil-Olivier Catherine,Weinberger Birgit,Wilkinson Tom,and von Koenig Carl Heinz Wirsing."Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations."2324547 20.1(2024):2324547.

Maestri Alvino,Park Su Eun,Fernandes Fiona,et al.A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)[J].2321035,2024,20(1):2321035.

Maestri Alvino,Park Su Eun,Fernandes Fiona,Li Zhongyi Lucy,Kim Yae-Jean,Kim Yun-Kyung...Banniettis Natalie.(2024).A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).

Maestri Alvino,Park Su Eun,Fernandes Fiona,Li Zhongyi Lucy,Kim Yae-Jean,Kim Yun-Kyung,Lee Jin,Park Ji Young,Kim Dong Hyun,Yang Gyongseon,Lim Hyunjung,Kim Jin Oh,Lupinacci Robert,Sterling Tina M.,Wilck Marissa,Esteves-Jaramillo Alejandra,and Banniettis Natalie."A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)."2321035 20.1(2024):2321035.

Gong Xiaoying,Zheng Canjie,Fang Quanjun,et al.A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023[J].2334917,2024,20(1):2334917.

Gong Xiaoying,Zheng Canjie,Fang Quanjun,Xu Wenjie,Yin Zhiying.(2024).A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023.

Gong Xiaoying,Zheng Canjie,Fang Quanjun,Xu Wenjie,and Yin Zhiying."A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023."2334917 20.1(2024):2334917.

Jiang Feng,Ye Xingui,Wang Ying,et al.Factors associated with pregnant women's willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study[J].2331870,2024,20(1):2331870.

Jiang Feng,Ye Xingui,Wang Ying,Tang Ning,Feng Jun,Gao Yuanxue,Bao Meiling.(2024).Factors associated with pregnant women's willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study.

Jiang Feng,Ye Xingui,Wang Ying,Tang Ning,Feng Jun,Gao Yuanxue,and Bao Meiling."Factors associated with pregnant women's willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study."2331870 20.1(2024):2331870.

Liu Pan,Yang Xiaohan,Zhao Hongyu,et al.High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies[J].2337161,2024,20(1):2337161.

Liu Pan,Yang Xiaohan,Zhao Hongyu,Liang Lihua,Chen Minchai,Yin Aihua.(2024).High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.

Liu Pan,Yang Xiaohan,Zhao Hongyu,Liang Lihua,Chen Minchai,and Yin Aihua."High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies."2337161 20.1(2024):2337161.

Pather Shanti,Muik Alexander,Rizzi Ruben,et al.Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary[J].463-466,2024,23(1):463-466.

Pather Shanti,Muik Alexander,Rizzi Ruben,Mensa Federico.(2024).Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary.

Pather Shanti,Muik Alexander,Rizzi Ruben,and Mensa Federico."Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary."463-466 23.1(2024):463-466.

Roa Jr Camilo C.,de los Reyes Mari Rose A.,Plennevaux Eric,et al.SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines[J].2301632,2024,20(1):2301632.

Roa Jr Camilo C.,de los Reyes Mari Rose A.,Plennevaux Eric,Smolenov Igor,Hu Branda,Gao Faith...Han Htay Htay.(2024).SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.

Roa Jr Camilo C.,de los Reyes Mari Rose A.,Plennevaux Eric,Smolenov Igor,Hu Branda,Gao Faith,Ilagan Hannalyn,Ambrosino Donna,Siber George,Clemens Ralf,and Han Htay Htay."SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines."2301632 20.1(2024):2301632.